ONCY: the cash flow

MyFinsight

For the year ending 2025-12-31, ONCY had -$5,877K decrease in cash & cash equivalents over the period. -$20,118K in free cash flow.

Cash Flow	2025-12-31
Net loss	-28,759
Depreciation of property and equipment	70
Noncash lease expense	288
Stock-based compensation expense	3,104
Issuance of shares for services	3,467
Unrealized foreign exchange gains	137
Change in fair value of warrant derivative	-153
Fair value loss from sepa arrangement	-388
Value of shares issued for sepa arrangement commitment fees	440
Other receivables	-3
Prepaid expenses	-580
Accounts payable	2,932
Accrued liabilities	-360
Pancreatic cancer action network (pancan) receivables and payables	-1,682
Operating lease liabilities	-293
Net cash used in operating activities	-20,112
Acquisition of property and equipment	6
Net cash used in investing activities	-6
Proceeds from exercise of warrant derivative	0
Proceeds from issuance of common stock-At The Market Offering Agreement	11,767
Proceeds from issuance of common stock-Standby Equity Purchase Agreement	2,348
Proceeds from stock option exercise	32
Other	-27
Net cash provided by financing activities	14,120
Effect of exchange rate changes on cash and cash equivalents	121
Net decrease in cash and cash equivalents	-5,877
Cash and cash equivalents, beginning of year	11,079
Cash and cash equivalents, end of year	5,202

Unit: Thousand (K) dollars (except for numbers of shares and EPS).